PR6512

Castrate-resistant prostate cancer (CRPC).

Summary
Cancer Type	prostate-cancer
Subtype	CRPC
Grade	NA
Stage	G4+5, T4, N1
Ethnicity	Western
Gender	M
Age	78
Pathology Diagnosis	Castrate-resistant prostate cancer (CRPC).
Biopsy Site	primary
Treatment History	HT
Pathology QC	Poorly differentiated carcinoma with massive necrosis(PR6511-H455/4 30/8), poorly differentiated carcinoma with part of papillary structure (PR6511-H455/4+C 8/11), poorly differentiated prostate adenocarcinoma; P504(2~3+), 34bE12(nearly 1~2%: 1+), CK8(3+), PSA(1~2+), Nkx3.1(3+), AR(3+), p63(1+).
Special Features	CRPC, model expansion is needed prio to study.
Mouse Strain	Rag2-/-?C-/-, NSG
TMA	NA
Viral Status in PDX	NA
Available In	CB_UK
RNA Seq	P4
Exome Seq	P3